← Back to Clinical Trials
Recruiting NCT06774508

NCT06774508 Feasibility of High-intensity Functional Exercise with Simultaneous Cognitive Challenge for Older People with Falls Risk

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06774508
Status Recruiting
Phase
Sponsor Umeå University
Condition Accidental Falls
Study Type INTERVENTIONAL
Enrollment 33 participants
Start Date 2025-02-17
Primary Completion 2025-09-01

Eligibility & Interventions

Sex All sexes
Min Age 75 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
HIFE+cogHIFE

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 33 participants in total. It began in 2025-02-17 with a primary completion date of 2025-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the feasibility of a high-intensity functional exercise program with simultaneous cognitive challenge (HIFE+cog) among older people at risk of falls. The evaluation design and intervention development will be assessed with the following specific aims: 1. To investigate the acceptability and safety of the HIFE+cog program in older people at risk of falls, and the methods used in the study by evaluating recruitment, compliance with the intervention, severity of adverse events reported, and participant experiences. 2. To measure key outcome variables, including completion rates, missing data, estimates, variances, and 95% confidence intervals for between-group differences. The study is designed as a randomized controlled pilot trial. Eligible participants will be randomized to either the intervention group (HIFE+cog) or the active control group (HIFE) to partake in individually tailored exercise, supervised and progressed by a physiotherapist, two times per week for 3 months.

Eligibility Criteria

Inclusion Criteria: * aged 75 years or older * moderate risk of falling (feeling unsteady or afraid of falling, or having fallen in the past year, with a self-selected gait speed ≤0,8 m/s or TUG \>15 s without walking aid) * can walk independently indoors, without a walking aid * can walk 500m independently outdoors, with or without a walking aid Exclusion Criteria: * a high fall risk (≥2 falls in the past year, serious injury e.g. hip fracture from a fall in the past year requiring medical care, or inability to get up from the floor after a fall) * Mini-Mental State Examination (MMSE) score \<24 or dementia diagnosis * a medical condition that may affect participation in high-intensity gait, balance, and leg strength exercise, or other movement-related conditions affecting exercise or tests (e.g., pain, dizziness, visual or hearing impairment)

Contact & Investigator

Central Contact

Annika Toots, PhD

✉ annika.toots@umu.se

📞 0046 90 7866329

Principal Investigator

Annika Toots, PhD

PRINCIPAL INVESTIGATOR

Umeå University

Frequently Asked Questions

Who can join the NCT06774508 clinical trial?

This trial is open to participants of all sexes, aged 75 Years or older, studying Accidental Falls. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06774508 currently recruiting?

Yes, NCT06774508 is actively recruiting participants. Contact the research team at annika.toots@umu.se for enrollment information.

Where is the NCT06774508 trial being conducted?

This trial is being conducted at Umeå, Sweden.

Who is sponsoring the NCT06774508 clinical trial?

NCT06774508 is sponsored by Umeå University. The principal investigator is Annika Toots, PhD at Umeå University. The trial plans to enroll 33 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology